FDA, Police Arrest 6 in Swoop On Accra Pubs for Sale of Illicit, Unregistered Products

The Food and Drugs Authority (FDA) in Ghana, in a joint intelligence-led operation with the Ghana Police Service, recently apprehended six individuals for the sale of illicit and unregistered products at three pubs in Accra. The seized items included dangerous substances such as nitrous oxide (laughing gas), unregistered shisha products, codeine-based medicines, and suspected cannabis-infused beverages. This enforcement action underscores the FDA's unwavering commitment to safeguarding public health and highlights the stringent regulatory framework in Ghana that prohibits the manufacture, importation, distribution, and sale of products not duly registered and approved by the Authority. The arrests signal a heightened focus on illicit trade, with offenders facing administrative sanctions or criminal prosecution under the Public Health Act, 2012 (Act 851).

In a significant move to curb the proliferation of harmful and unregulated products, the Food and Drugs Authority (FDA) of Ghana, in close collaboration with the Ghana Police Service, conducted an intelligence-led operation in Accra, leading to the arrest of six individuals. The targeted swoop on three pubs in the Kantamanto area of Nungua uncovered a cache of illicit items, including nitrous oxide, unregistered shisha products, Benylin containing codeine, and suspected cannabis-infused fruit juices. This operation is not an isolated incident but forms part of the FDA's ongoing nationwide enforcement drive aimed at ridding the market of unauthorized and potentially dangerous products.

The sale of unregistered and illicit products poses a severe threat to public health and safety, undermining the integrity of the regulated market and exposing consumers to unknown risks. The substances seized, particularly nitrous oxide and codeine-based medicines, carry a high potential for abuse, making their unregulated sale a critical concern for public health authorities. This article delves into the legal framework underpinning such enforcement actions in Ghana, examining the statutory powers of the FDA, the implications for offenders, and the broader context of regulatory compliance for businesses operating within the country.

Ghana's regulatory landscape for food, drugs, and related products is primarily governed by the Public Health Act, 2012 (Act 851), which consolidated and updated earlier fragmented legislation. Prior to Act 851, the Food and Drugs Law, 1992 (PNDCL 305B), established the Food and Drugs Board (the precursor to the FDA) and laid down initial controls over the manufacture, importation, exportation, distribution, use, and advertisement of food, drugs, cosmetics, chemical substances, and medical devices. The Food and Drugs (Amendment) Act, 1996 (Act 523), further amended PNDCL 305B.

The Public Health Act, 2012 (Act 851), now serves as the comprehensive legal instrument empowering the FDA. Parts 6, 7, and 8 of Act 851 specifically delineate the Authority's responsibilities for regulating food safety, pharmaceuticals, medical devices, cosmetics, household chemicals, and tobacco products, all with the overarching goal of protecting public health. A cornerstone of this regulatory regime is the mandatory registration of products. Section 97(1) of Act 851 explicitly prohibits any person from manufacturing, importing, exporting, distributing, selling, or supplying food, or exposing food for sale, unless that food has been registered by the FDA. Similar provisions apply to drugs, cosmetics, medical devices, and chemical substances, requiring their registration before they can be legally dealt with in Ghana. The FDA's Enforcement Directorate is specifically mandated to investigate non-compliance, conduct market surveillance, and collaborate with other state institutions, including the Ghana Police Service, to apprehend offenders and secure prosecutions.

The recent arrests in Accra highlight several critical aspects of Ghana's regulatory enforcement. The primary legal violation at play is the sale of unregistered products, which directly contravenes Section 97(1) of the Public Health Act, 2012 (Act 851). This section mandates FDA registration for all food products before they can be placed on the market. While the excerpt specifically mentions 'food and drugs laws' being contravened, the scope of FDA's mandate under Act 851 extends to cosmetics, medical devices, and household chemical substances, encompassing the unregistered shisha products and potentially the nitrous oxide, depending on its classification.

Furthermore, the nature of the seized products introduces additional layers of legal complexity. Nitrous oxide, commonly known as laughing gas, and codeine-based medicines like Benylin, are substances with significant potential for abuse. Their unregulated sale not only bypasses the registration requirement but also raises concerns under sections of Act 851 pertaining to the sale of harmful substances or those not meeting prescribed standards. The presence of suspected Indian hemp and cannabis-infused beverages points to potential violations of narcotics control laws in addition to the FDA's regulations, necessitating the collaboration with the Ghana Police Service. The FDA's Enforcement Directorate is equipped to handle such multi-faceted investigations, working with seconded police officers and liaising with the judiciary for prosecutions.

The FDA's enforcement powers are robust, allowing for intelligence-led operations, seizures of non-compliant products, and the imposition of sanctions. For first-time offenders, administrative sanctions, including fines, may be imposed, while more serious or repeat violations can lead to criminal prosecution. Penalties under the Food and Drugs Law, 1992 (PNDCL 305B), which informed Act 851, could include fines not exceeding five hundred penalty units or imprisonment for up to two years, or both. This tiered approach allows the FDA flexibility in addressing various levels of non-compliance, from minor infractions to serious criminal offenses that endanger public health. The ongoing nature of these operations, as stated by Nana Kwame Dartey of the FDA, signals a sustained commitment to market surveillance and enforcement, ensuring that businesses adhere to regulatory standards.

The recent arrests in Accra serve as a stark reminder to businesses and individuals operating in Ghana of the strict regulatory environment governing food, drugs, cosmetics, and other regulated products. The collaborative efforts between the FDA and the Ghana Police Service demonstrate a robust and coordinated approach to tackling illicit trade and protecting public health. Legal practitioners advising clients in the manufacturing, import, distribution, and retail sectors must emphasize the critical importance of product registration and adherence to all provisions of the Public Health Act, 2012 (Act 851).

For businesses, conducting thorough due diligence on all products, ensuring proper licensing, and maintaining up-to-date registration with the FDA are not merely bureaucratic hurdles but essential legal obligations designed to prevent severe penalties, including substantial fines, product seizures, and potential imprisonment. Practitioners should also advise on robust internal compliance mechanisms and regular training to mitigate risks. The FDA's commitment to sustained surveillance and enforcement indicates that such operations will continue, making proactive compliance a non-negotiable aspect of doing business in Ghana's regulated sectors. The public is also urged to be vigilant and report suspicious activities, reinforcing a collective responsibility in safeguarding the nation's health.